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Edited by Robert B. RussellAbstract Combinations of multiple linear regressions, genetic
algorithms and artiﬁcial neural networks were utilized to develop
models for seeking quantitative structure–activity relationships
that correlate structural descriptors and inhibition activity of
adenosine deaminase competitive inhibitors. Many quantitative
descriptors were generated to express the physicochemical prop-
erties of 70 compounds with optimized structures in aqueous
solution. Multiple linear regressions were used to linearly select
diﬀerent subsets of descriptors and develop linear models for pre-
diction of log(ki). The best subset then fed artiﬁcial neural net-
works to develop nonlinear predictors. A committee of six
hybrid models – that included genetic algorithm routines together
with neural networks – was also utilized to nonlinearly select
most eﬃcient subsets of descriptors in a cross-validation proce-
dure for nonlinear log(ki) prediction. The best prediction model
was found to be an 8-3-1 artiﬁcial neural network which was
fed by the most frequently selected descriptors among these sub-
sets. This prediction model resulted in train set root mean sum
square error (RMSE) of 0.84 log(ki) and prediction set RMSE
of 0.85 log(ki) (both equivalent of 0.10 in normal range of
log(ki)) and correlation coeﬃcient (r
2) of 0.91.
 2007 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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As a critical enzyme in purine metabolism, adenosine deam-
inase (ADA) removes the amino group of adenine moiety from
adenosine and 2 0deoxiadenosine to produce inosine and
2 0deoxiinosine, respectively. Although it is found in all tissues
within the human body, the highest amount of adenosine
deaminase is detected in lymphoid tissues [1]. So as expected,
its failure to work properly aﬀects the immune system the
most. Severe combined immune deﬁciency (SCID) is the most
famous eﬀect of ADA absence on immune system. Also overAbbreviations: QSAR, quantitative structure–activity relationship;
RMSE, root mean sum square error; ADA, adenosine deaminase
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doi:10.1016/j.febslet.2006.12.050activity of ADA has been reported in AIDS and Parkinson af-
fected cases [2].
Adenosine administration has shown to be cardio-protective
in some myocardial ischemia models, and endogenous adeno-
sine in myocardial tissue may be cardio-protective as well. Also
the extracellular adenosine is useful against excessive excit-
atory amino acid-mediated stimulation and seizures. ADA
inhibitors can be useful as auxiliary drugs to treat the above-
mentioned diseases by protecting adenosine from degradation.
Furthermore, since some drugs used for cancer chemo-therapy
are substrates of ADA, inhibition of this enzyme can improve
the eﬀect of chemo-therapy. Also inhibition of ADA can be
useful to treat some viral infections and lymphoproliferative
disorders [2].
Quantitative structure–activity relationship (QSAR) pro-
vides drug designers with valuable information used to im-
prove the eﬃciency of drugs. Using QSAR techniques,
quantitative structural descriptors which are in close relation
with molecular activity are selected and then the relation be-
tween such descriptors and molecular activity is described by
developing suitable quantitative models. Diﬀerent kinds of
regression analyses, genetic algorithms and artiﬁcial neural
networks can be used as techniques of selecting descriptors
and developing QSAR models. In addition to be guides for
eﬀective drug design, predictive ability of such models can be
used to forecast the approximate activity of the designed mol-
ecules before their synthesis and assay in laboratory. In this
way, the research cost can be minimized. Outstanding exam-
ples of such QSAR models have been developed by Jurs and
Mattioni [16], Jalali-Heravi and Parastar [17] and Douali
et al. [18].
In this research, we aimed to establish QSAR models with
the predictive ability for ADA competitive inhibitors. In a pre-
vious work by Moosavi-Movahedi et al., four numerical
descriptors were generated for a library of 24 adenosine-like
compounds [19]. The relations between those descriptors and
the binding aﬃnity of compounds were then investigated using
the multiple linear regression analysis (MLR) resulting in the
following equation:
logðBAÞ ¼ 15:557 logðVOLÞ þ 13:165ðECN 1Þ1
þ 1:69 logðDIPMÞ  0:560ðHPOST Þ1 þ 106:42;
where VOL is the molecular volume, ECN1 is the electric
charge on atom N1 of purine ring, DIPM is the molecular di-
pole moment and HPOST is the highest of positive charge on
the molecule. In a second work, we classiﬁed those 24ation of European Biochemical Societies.
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(log(ki) > 2) groups. Then, using logistic regression together
with artiﬁcial neural networks and the same four descriptors,
we developed models with the ability to classify such com-
pounds into those activity groups [20]. The equation obtained
in this work was as follows:
OUT ¼ 82:117  logðVOLÞ  6:820  HPOST  232:485:
Using this equation, the compounds with OUT > 0 can be con-
sidered active and vice versa. In the current research we in-
creased the compound library from 24 molecules to 70 ones
and generated more descriptors. We used this extensive library
together with linear as well as nonlinear methods, to develop
new QSAR models with the ability to predict the approximate
value of the log(ki) of ADA competitive inhibitors in contrast
with the previous work in which our models could only predict
the activity classes of such compounds.2. Material and methods
2.1. Dataset
The 70 compounds – that were used for model development – were
assigned with ki values as indicators of their inhibitive ability. The
structures and ki values of all compounds came from the literature.
This dataset was selected from a pool of about 140 compounds, all
claimed to be inhibitors of ADA. Half of these 140 compounds were
neglected due to considerable diﬀerences in inhibition mechanisms, un-
known assay conditions and vague structural information. Although
some of the selected compounds are still semi or tight binding inhibi-
tors, their dissociation indices is not zero; thus, do not bind the enzyme
covalently. In spite of the fact that the existence of such compounds
could deteriorate the errors in our models, they could enrich our data-
set and provide our models with more patterns and help them to be
trained better. However, all of the selected inhibitors bind the active
site of the enzyme and can be regarded as competitive inhibitors.
Although in many compounds, the adenine core (Fig. 1) has under-
gone small structural changes, it is conserved in some others. The
structures of all compounds are shown in Fig. 2. The log(ki) values
of the 70 selected inhibitors (Table 1) ranged between 5.70 and
2.83 (mean = 0.13). A set of 10 compounds were randomly removed
from the dataset to be used as the prediction set (PSET). The PSET
was remained unchanged through all QSAR modeling. The log(ki) of
this set spanned all the dataset. The remaining 60 compounds were
used as the training set (TSET).
2.2. Model development and evaluation
The log(ki) of the compounds were used as the dependent variable in
model development. Also the independent variables in each model
were some selected quantitative descriptors. In neural network based
QSAR models, we performed a leave 10 out procedure (cross-valida-
tion) to avoid any possible bias in selecting testing set individuals.
To do this, in such QSAR models, we built six models by removing
10 CVSET individuals from the TSET, remaining other 50 TSET ones
each time. This was done in a way that each compound was used 5
times as a TSET member and once as a CVSET one. In this way, we
reported the average result of six diﬀerent simulations. The structures
of all neural networks were optimized for minimum root mean square
error (RMSE) as a performance benchmark.N N
N N1
N
Fig. 1. Adenine core on which N1 atom is indicated.2.3. Structure entry and optimization
All calculations were performed using Gaussian 98W program series
[26]. Geometry optimizations of 70 compounds were carried out at
B3LYP method employing 6-31G* basis set with no initial symmetry
restrictions and assuming C1 point group which were drawn in Hyper-
Chem. Using these software, all compounds were sketched and opti-
mized with regards to their spacial properties that were indicated in
references. We computed the harmonic vibrational frequencies to con-
ﬁrm that an optimized geometry correctly corresponds to a local min-
imum that has only real frequencies.
We used Onsager model [27] to consider non-speciﬁc solvent eﬀect.
Continues solution model eﬀect has been utilized as an eﬀective meth-
od to investigate many molecular properties such as conformational
equilibrium, rotational barriers and charge distributions in solution.
In order to ﬁgure out what eﬀect a solvent environment can have on
the structures in this work, we have optimized all structures in H2O
solvent. In Onsager model, the molecule is surrounded by a spherical
continuous cavity of solvent. As our calculated results indicate, the sol-
vent stability (e0 = 78.39) gained by all compounds is about 2–10 kcal/
mol more than gas phase. So we used the outputs of Gaussian with
considering solvent eﬀect for descriptor generation.2.4. Descriptor generation and objective feature selection
Diﬀerent types of numerical descriptors were generated to describe
each compound. These descriptors are categorized in topological, geo-
metrical, MoRSE [28,29], RDF [28,30], GETAWAY[31,32], autocor-
relations [28] and WHIM [33,34] groups. Totally 644 descriptors
were generated that were too many to be ﬁtted in our models. So we
had to reduce the number of descriptors through an objective feature
selection which was performed in three steps. First, descriptors that
had the same value for at least 80% of compounds within the dataset
were removed. Next step, descriptors with correlation coeﬃcient less
than 0.3 with the dependent variable (log(ki)) were regarded redundant
and removed. Finally, since highly correlated descriptors provide
approximately identical information, performing a pair wise correla-
tion, one of two descriptors was randomly removed if their correlation
coeﬃcient exceeded 0.75. After these three steps, the number of
descriptors was reduced to 45.2.5. QSARs-Type I: linear feature selection and linear modeling
Forward Wald statistics together with multiple linear regressions
(MLRs) was used to establish the ﬁrst type of QSAR models. Using
minimum RMSE of TSET as a benchmark, subsets of descriptors were
examined for establishing the best linear quantitative structure–activity
relationship. The size of descriptor subset used for model establish-
ment was increased until no improvement was seen. Variance inﬂation
factor (VIF) was calculated for each descriptor and models with VIF
over 10 were ignored. Among remaining models, that which resulted
in minimum RMSE and used the smallest descriptor subset was re-
garded the best. After model development with TSET members, the
best model was further examined by the PSET compounds.2.6. QSARs-Type II: linear feature selection and nonlinear modeling
The best subset of descriptors selected in QSARs-Type 1 fed neural
networks to develop QSARs-Type 2. The neural networks used in this
study were all three-layer fully connected feed-forward networks. Such
networks are supposed to identify the nonlinear relationship between
the structural descriptors and inhibition activity of compounds, if there
was any. The networks were trained using the TSET members and the
BFGS [35] (Broyden-Fletcher-Goldfarb-Shanno) quasi-newton algo-
rithm.
Each neuron in the network was connected to all neurons in neigh-
boring layer(s) through adjustable weights. Network training is the
process of adjusting such weights somehow that the error is minimized.
The number of input layer neurons is equal to the number of descrip-
tors. We had only one output layer neuron, while the number of hid-
den layer neurons was a matter of optimization. It is generally said that
the ratio of training pairs to the whole network weights should be be-
tween 1 and 3 [31]. Since the numbers of input and output neurons are
constant, the approximate number of hidden neurons can be calculated
using this rule. It is said that if the ratio is less than 1, then the network
simply memorizes the train set or in other words, gets over-trained;
while if it exceeds 3, then the network fails to ﬁnd a relationship
Fig. 2. Chemical structures of compounds used in our dataset.
508 S.H. Sadat Hayatshahi et al. / FEBS Letters 581 (2007) 506–514between dependent and independent variables. The descriptor values
were ﬁrst ranged between zero and one in order to ensure that some
descriptors are not weighted more heavily than others due to their nat-
ure. The values of log(ki) were ranged between zero and one too. Theﬁrst layer only fed network with the descriptors, while in hidden and
output layers, a sigmoid function acted on summation of incoming
weights. A bias neuron was added to the input and hidden layers to
prevent network collapse.
Fig. 2 (continued)
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layer, learning rate and the number of iterations – were optimized
using both RMS errors of TSET and CVSET as benchmarks.
Although an excess in values of these factors may decrease theTSET-RMSE, it increases the risk of chance correlations and over-
training which can be indicated by an increase in CVSET-RMSE.
Hence, in order to optimize the network properties, we increased them
until no improvement was seen in either TSET or CVSET-RMS errors.
Fig. 2 (continued)
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Genetic algorithm was utilized as the means for nonlinear feature
selection. The neural networks with similar properties to those used
in type 2 models were used to calculate the ﬁtness function of genetic
algorithms. The optimal ﬁtness function as the object of minimization
by genetic algorithm was found to be as follows:F ¼ rmseCVSET þ 0:2jrmseTSET  rmseCVSETj:
Although this function uses the CVSET-RMSE as the major bench-
mark of model credibility, it also prevents large gaps between RMS
errors of TSET and CVSET. The hybrid model was repeated for six
CVSETs selecting a set of descriptors for each. In all genetic
Table 1
70 compounds used for model development together with their log(ki)
and references
No log(ki) Ref.
1 5.00 [3]
2 5.70 [4]
3 1.79 [5]
4 3.30 [6]
5 2.33 [7]
6 0.42 [8]
7 0.34 [9]
8 0.60 [9]
9 0.08 [9]
10 0.77 [9]
11 2.15 [10]
12 2.57 [11]
13 3.05 [11]
14 3.30 [12]
15 0.45 [13]
16 0.80 [14]
17 2.00 [14]
18 1.46 [2]
19 0.52 [15]
20 0.96 [2]
21 1.00 [2]
22 1.11 [2]
23 2.00 [2]
24 1.95 [19]
25 1.11 [19]
26 0.51 [19]
27 1.89 [19]
28 1.94 [19]
29 2.21 [19]
30 2.28 [19]
31 0.51 [19]
32 1.32 [19]
33 1.11 [19]
34 0.51 [19]
35 2.21 [19]
36 2.28 [19]
37 0.74 [19]
38 2.34 [19]
39 1.88 [19]
40 1.65 [19]
41 2.11 [19]
42 0.85 [19]
43 1.08 [19]
44 1.15 [19]
45 1.56 [19]
46 2.15 [19]
47 2.18 [21]
48 0.80 [22]
49 2.00 [22]
50 0.26 [22]
51 0.08 [22]
52 0.08 [22]
53 2.83 [23]
54 2.38 [23]
55 2.38 [23]
56 2.08 [23]
57 2.30 [23]
58 2.83 [23]
59 2.54 [23]
60 1.98 [23]
61 1.04 [24]
62 0.90 [24]
63 0.52 [25]
64 0.88 [25]
65 0.52 [25]
66 2.99 [25]
67 3.05 [25]
68 3.29 [25]
69 3.12 [25]
70 3.02 [25]
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ones indicated descriptors that would participate in predictive models
and vice versa. All chromosome bits were mutated with the probability
of 0.08 and two point crossovers were imposed to chromosomes with
the probability of 0.8.
Regarding to the volatile nature of chromosomes in genetic algo-
rithm, even very good descriptors may be removed from them and
some bad ones added at very ﬁnal generations. To compensate this
random nature, the selection frequency of each descriptor was calcu-
lated in each cross-validation during 100 generations of genetic algo-
rithm. Then neural network models were developed using descriptors
with highest rates of selection frequencies. The experience showed that
such sets of descriptors improve the prediction ability of neural net-
works in comparison to the set which was selected in last generation
of genetic algorithm. Also seeking overall results in a unique model,
the selection frequencies of descriptors obtained for all six cross-valida-
tions were integrated and those with highest frequencies were selected
to feed a neural network. The best models in each cross-validation
analysis and the last unique model were further examined by the PSET.3. Results
3.1. QSARs-Type 1
The best descriptor set selected by type 1 models contained
six descriptors which were related to the dependent variable
as follows:
logðkiÞ ¼ 1:809þ 53:819HATS6v 1:818Mor14u
 0:929Mor8uþ 0:494Mor6u
 0:08RDF25mþ 0:009TIE:
Table 2 shows some details about these descriptors. Pair wise
correlations for this six descriptors ranged from 0.04 to 0.63
(mean = 0.31). Examining the training as well as the prediction
set cases with this equation resulted in TSET-RMSE of 0.80
log(ki) and PSET-RMSE of 1.34 log(ki) (0.09 and 0.16 in nor-
mal range of log(ki), respectively). Also the correlation coeﬃ-
cient (r2) calculated for this model was as good as 0.84.
Since the descriptors with greater coeﬃcients are more deter-
mining in regression equations, we can conclude that accord-
ing to this equation, the most important descriptor is
HATS6v and the least determining one is TIE.
3.2. QSARs-Type 2
The six descriptors which were selected by the optimal type 1
model were then fed the neural networks to establish the type 2
models. The optimal network architecture – which resulted in
the best TSET and CVSET-RMS errors – was found to be 6-3-
1. Six networks with diﬀerent CVSETs were developed, each of
which was repeated three times to avoid chance correlations.
These models resulted in average TSET-RMSE of 0.85 log(ki)
and PSET-RMSE of 1.26 log(ki) (0.10 and 0.14 in normal
range of log(ki), respectively). The 0.05 log(ki) deterioration
of TSET-RMSE in comparison to the type 1 model was
expectable due to a 10 case decrease from the training set. In
spite of this deterioration, the correlation coeﬃcient (r2) of this
type of models was similar to that of the previous model and
equal to 0.84. However, the PSET-RMSE showed an improve-
ment in type 2 model.
3.3. QSARs-Type 3
Utilizing the hybrid model of genetic algorithm and neural
network, the best sets of descriptors were selected for each of
six cross-validation sets. The best set which contained 16
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Fig. 3. Plot of predicted versus observed log(ki) for 10 prediction set (PSET) members using three QSAR types. The RMS errors and the correlation
coeﬃcient (r2) for QSAR types 1, 2 and 3 were 1.38, 1.26, 0.85, 0.84, 0.84 and 0.91, respectively.
Table 2
Descriptors selected by models type 1 and 3 for prediction of ADA inhibition
Name Description Type Model type Ref.
Mor6u 3D Morse signal 6 unweighted 3D-MoRSE 1 [28,29]
Mor8u 3D Morse signal 8 unweighted 3D-MoRSE 1,3 [28,29]
Mor14u 3D Morse signal 14 unweighted 3D-MoRSE 1,3 [28,29]
RDF25m Radial Distribution Function 2.5 weighted by atomic masses RDF 1,3 [28,30]
HATS6v Leverage-weighted autocorrelation of lag 6 weighted by atomic van der Waals volumes GETAWAY 1,3 [31,32]
R4v+ R maximal autocorrelation of lag 4 weighted by atomic van der waals volumes GETAWAY 3 [31,32]
P2e Second component shape directional WHIM index weighted
by atomic Sanderson electronegativitites
WHIM 3 [33,34]
GATS6e Geary autocorrelation of lag 4 weighted by atomic Sanderson electronegativitites Autocorrelation 3 [28]
MATS5m Moran autocorrelation of lag 6 weighted by atomic masses Autocorrelation 3 [28]
TIE E-state toppological parameter Geometrical 1 [28]
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PSET-RMSE of 0.92 log(ki) (0.09 and 0.11 in normal range of
log(ki), respectively). The descriptors’ total selection frequen-
cies were calculated by integrating their selection frequencies
in all six cross-validations. Several thresholds were then de-
ﬁned as the minimum total selection frequencies for choosing
sets of descriptors as network inputs. The best threshold de-
ﬁned the optimal set that contained eight descriptors and re-
sulted in TSET-RMSE of 0.84 log(ki) and PSET-RMSE of
0.85 log(ki) (both equivalent of 0.10 in normal range of
log(ki)). Also the correlation coeﬃcient (r
2) of this best model
showed good improvement and was as good as 0.91. Four out
of eight descriptors were previously selected by type 1 model.
Fig. 3 shows the comparative scatter gram of predicted versus
observed log(ki) values for 10 compounds of the prediction set
with three QSAR types.
3.4. Chance correlations
To ensure avoiding chance correlations, the log(ki) was ran-
domly scrambled producing a new set of values for dependent
variable. The new set was utilized to develop the three types ofmodels under the same experimental conditions. No signiﬁcant
relationship was found between structural properties and
inhibitory activity of compounds, when training the models
with the new random set. Using this set, the best type 1 model
led to TSET-RMSE of 2.82 log(ki) and PSET-RMSE of 3.16
log(ki) (0.33 and 0.37 in normal range of log(ki), respectively).
The best type 2 model resulted in TSET-RMSE of 2.26 log(ki)
and PSET-RMSE of 3.90 log(ki) (0.27 and 0.46 in normal
range of log(ki), respectively). The best type 3 model produced
TSET-RMSE of 2.11 log(ki) and PSET-RMSE of 2.71 log(ki)
(0.25 and 0.32 in normal range of log(ki), respectively). Very
high RMS errors produced using the random set of dependent
variables compared to that produced using the real set is a
proof of lacking chance correlations.4. Discussions and conclusions
The descriptors suggested by QSAR type 1 and 3 are de-
scribed in Table 2. According to presented references, most of
these descriptors give valuable information about the molecu-
S.H. Sadat Hayatshahi et al. / FEBS Letters 581 (2007) 506–514 513lar geometry as well as topology with regard to diﬀerent atomic
properties. The best QSARmodel was developed using some of
these descriptors that were selected by a hybrid model in which
genetic algorithm operated as a nonlinear descriptor selector
and neural network as a ﬁtness calculator. In order to minimize
the eﬀect of bad mutations and crossovers in late generations of
genetic algorithm that leads to removing conserved descriptors
and inserting less eﬃcient ones from and into the ﬁnal descrip-
tor set, we used the total selection time of each descriptor by ge-
netic algorithm as the determinant of involving it into the ﬁnal
descriptor set. The prediction set RMSE resulted by this model
was 0.85 log(ki) and its training set RMSE was 0.84 log(ki)
(both equivalent to 0.1 in normal range of log(ki)).
Relatively high RMS errors resulted by models are because
of two reasons. First, by its nature, RMSE is highly dependent
to the range of the dependent variable. Generally speaking,
good models result in RMSE values much lower than half this
range. The range of log(ki) in our dataset was 8.53; and the
best type 3 models resulted in PSET RMSE of 0.84 which is
much lower than half the range (4.26). In order to be compa-
rable with results of similar QSAR attempts, we reported
RMSE values in normal range of log(ki) as well. The second
reason is the possible errors in experimental data used in
QSAR development. From an experimental point of view,
ADA is a complicated enzyme and is not so easy to assay. It
has more than one isozyme and sometimes is reported to dis-
obey Michaelis–Menten equations [36]. In this way, possible
errors in reporting the ki values, due to assay diﬃculties, could
adversely aﬀect our QSAR results. In addition, as mentioned
before (Section 2.1), although all of the selected 70 compounds
can be regarded as competitive inhibitors, some are semi or
tight binding; which could have aﬀected the results of the
QSAR attempts. In spite of these facts, the RMSE values re-
sulted by our models are still good enough to make these mod-
els trustable in future predictions.
The results of three QSAR models tell us that nonlinear
descriptor selection and activity prediction models do better
than their linear counterparts. This fact – that is also con-
ﬁrmed by other QSAR attempts [14,15] – is due to complicated
relations between structure and activity of compounds.
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